Picture of Equillium logo

EQ — Equillium News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Equillium Inc expected to post a loss of 27 cents a share - Earnings Preview

* Equillium Inc  EQ.OQ   EQ.O  is expected to show a rise in
quarterly revenue when it reports  results on May 10
(estimated). 
    * The La Jolla California-based  company is expected to
report
revenue of $6.736 million, according to the mean estimate from 5
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Equillium Inc is
for a
loss of 27 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 92.2%
in the last three months. ​
    * Wall Street's median 12-month price target for Equillium
Inc is
$7​, above​ its last closing price of $0.53. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.41        -0.03      0.08      Beat    407.7
 Sep. 30 2022  -0.39       -0.38      -0.40     Missed  -6
 Jun. 30 2022  -0.41       -0.41      -0.41     Met     1.2​
 Mar. 31 2022  -0.37       -0.37      -0.45     Missed  -20.8
 ​​Dec.        -0.37       -0.34      -0.36     Missed  -5.3
 31 2021                                                
 Sep. 30 2021  -0.34       -0.34      -0.35     Missed  -3.4​
 Jun. 30 2021  -0.30       -0.31      -0.31     Met     -1.1
 Mar. 31 2021  -0.33       -0.32      -0.33     Missed  -2.5
 This summary was machine generated May 8 at 11:09 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Equillium

See all news